Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [¹⁸F]fallypride positron emission tomography

Abstract

The protocol is feasible for use in AD and represents the first step towards establishing dose-occupancy relationships across older clinical populations.